Throughout the last year, SOT Council has engaged in conversations and activities around the mega focus of “enhancing the stature and recognition of toxicology among other scientists” with the goal of furthering our strategic objectives to foster the integration of other scientific disciplines with toxicology and to increase partnerships/collaboration with scientific societies.
As SOT President Patricia Ganey shared in her most recent President’s Message, one of the actions Council took toward this goal was applying for membership to the Federation of American Societies for Experimental Biology (FASEB). On behalf of the SOT Council, I am pleased to announce that our application was accepted, and SOT became an official member of FASEB on July 1.
FASEB and SOT jointly announced the news through the message below.
I look forward to engaging with FASEB members on behalf of SOT and toxicology and encourage other SOT members to pursue new opportunities available as part of this partnership.
SOCIETY OF TOXICOLOGY BECOMES FASEB MEMBER
On July 1, the Society of Toxicology (SOT) joined the Federation of American Societies for Experimental Biology (FASEB), bringing the number of Federation members to 31.
“We are very proud to have the Society of Toxicology join the Federation. With its large, diverse membership in academic, government, and industrial settings, the society will strengthen our advocacy and broaden the perspectives of our policy deliberations,” said Thomas O. Baldwin, PhD, FASEB President. “This is a great opportunity and we look forward to developing the partnership.”
Founded in 1961, SOT represents the wide variety of practicing toxicologists in the US and abroad. SOT promotes the acquisition and utilization of knowledge in toxicology, aids in the protection of public health, and has a strong commitment to toxicology education.
“SOT and its members welcome the opportunity to collaborate with the other FASEB members,” said John B. Morris, PhD, SOT President 2016–2017. “The concerns of toxicologists are frequently shared by biologists, biomedical researchers, and other related scientists, and we look forward to working alongside them on issues of importance to our scientific communities.”